.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advances in Systemic Therapy for Melanoma

EP. 1: Metastatic Melanoma: The Immunotherapy Approach

October 3rd 2017

EP. 2: The Value of Ipi/Nivo in Treating Metastatic Melanoma

October 3rd 2017

EP. 3: Managing Brain Metastases in Melanoma

October 3rd 2017

EP. 4: Choosing the Right Therapy for Melanoma

October 3rd 2017

EP. 5: Data in Melanoma: Observing Trials and Unmet Needs

October 3rd 2017

EP. 6: Targeting NRAS Mutations in Metastatic Melanoma

October 3rd 2017

EP. 7: Melanoma: Mechanisms of Resistance to Therapy

October 3rd 2017

EP. 8: Sequencing Therapies in BRAF Wild-Type Melanoma

October 3rd 2017

EP. 9: Considering Chemotherapy's Value in Melanoma

October 3rd 2017

EP. 10: Emerging Agents and Combinations for Advanced Melanoma

October 3rd 2017

EP. 11: Alternative Approaches to Treating Melanoma

October 3rd 2017

EP. 12: Locoregional Therapy for Advanced Melanoma

October 3rd 2017

EP. 13: The Role of Lymphadenectomy in Node-Positive Melanoma

October 3rd 2017

EP. 14: COMBI-AD: Dual-Targeted Therapy for Stage 3 Melanoma

October 3rd 2017

EP. 15: Advances in Treating Melanoma: Closing Thoughts

October 3rd 2017